Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Acelity
|
| gptkbp:acquisition |
gptkb:KCI_Medical
gptkb:Acelity Systagenix |
| gptkbp:awards |
gptkb:Quality_Awards
Best Places to Work Innovation Awards |
| gptkbp:category |
Infusion Therapy Products
Advanced Wound Care Continence Care Products Ostomy Care Products |
| gptkbp:ceo |
Karim Bitar
|
| gptkbp:clinical_trial |
Ongoing
|
| gptkbp:community_engagement |
Health Education Programs
Volunteer Programs Support for Local Charities |
| gptkbp:customer_base |
Hospitals
Clinics Patients Home Care Providers |
| gptkbp:employees |
5000+
|
| gptkbp:financial_performance |
Publicly Traded
Annual Reports Available Investor Relations Section on Website |
| gptkbp:founded |
gptkb:1978
|
| gptkbp:founder |
gptkb:James_A._Mc_Gowan
|
| gptkbp:global_presence |
Over 100 countries
|
| gptkbp:headquarters |
gptkb:Reading,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Convatec
|
| gptkbp:industry |
gptkb:hospital
|
| gptkbp:innovation |
gptkb:Insurance_Company
Sustainable Products Patient-Centric Solutions |
| gptkbp:mission |
To improve the lives of people with chronic conditions.
|
| gptkbp:parent_company |
gptkb:Coloplast
|
| gptkbp:partnerships |
gptkb:hospital
Research Institutions Patient Advocacy Groups |
| gptkbp:products |
Wound Care
Continence Care Infusion Devices Ostomy Care |
| gptkbp:region |
Global
|
| gptkbp:research_and_development |
Significant Investment
|
| gptkbp:revenue |
$1.5 billion (2020)
|
| gptkbp:stock_exchange |
gptkb:LSE
|
| gptkbp:sustainability_initiatives |
Environmental Responsibility
Social Responsibility Economic Responsibility |
| gptkbp:symbol |
CTEC
|
| gptkbp:vision |
To be the global leader in advanced wound care.
|
| gptkbp:website |
www.convatec.com
|